Supplementary Table S3.
Model Parameters
| Parameters | Equations | Explored Range |
Selected Values |
|||
|---|---|---|---|---|---|---|
| k1 | Strength of agr expression | S5 | [‒2, ‒1] | [0, 1] | ‒1.06 | 0.50 |
| k2 | Recovery rate of skin barrier integrity through skin turnover | S6 | [‒8, ‒7] | [0, 1] | ‒7.71 | 0.33 |
| k3 | Recovery rate of skin barrier integrity through placebo effects | S6 | [‒1, 0] | [1, 2] | ‒0.46 | 1.58 |
| k4 | Proliferation rate of S. aureus | S7 | [1‒2] | [0, 1] | 1.37 | 0.20 |
| k5 | Proliferation rate of CoNS | S8 | [‒2, ‒1] | [0, 1] | ‒1.26 | 0.25 |
| k6 | Secretion rate of IL-4/IL-13 through agr expression | S9 | [‒9, ‒8] | [2, 3] | ‒8.10 | 2.72 |
| k7 | Secretion rate of IL-4/IL-13 through other pathways | S9 | [‒6, ‒5] | [0, 1] | ‒5.02 | 0.70 |
| b1 | Inhibitory strength for agr expression through CoNS | S5 | [1, 2] | [0, 1] | 1.37 | 0.04 |
| b2 | Inhibitory strength for recovery of skin barrier through IL-4/IL-13 | S6 | [‒3, ‒2] | [0, 1] | ‒2.67 | 0.98 |
| b3 | Inhibitory strength for S. aureus proliferation through skin barrier | S7 | [‒7, ‒6] | [0, 1] | ‒6.11 | 0.60 |
| b4 | Inhibitory strength for elimination of Staphylococci through IL-4/IL-13 | S7, S8 | [‒3, ‒2] | [1, 2] | ‒2.71 | 1.51 |
| d1 | Degradation rate of skin barrier through skin turnover | S6 | [‒10, ‒9] | [1, 2] | ‒9.86 | 1.41 |
| d2 | Degradation rate of skin barrier through S. aureus | S6 | [‒9, ‒8] | [2, 3] | ‒8.33 | 2.32 |
| d3 | Killing rate of S. aureus by bacteriocins secreted from CoNS | S7 | [‒5, ‒4] | [2, 3] | ‒4.65 | 2.61 |
| d4 | Killing rate of S. aureus by AMPs | S7 | [0, 1] | [0, 1] | 0.55 | 0.39 |
| d5 | Elimination rate of S. aureus via turnover | S7 | [0, 1] | [0, 1] | 0.23 | 0.19 |
| d6 | Killing rate of CoNS via bacteriocins secreted from S. aureus | S8 | [‒9, ‒8] | [0, 1] | ‒8.14 | 0.59 |
| d7 | Killing rate of CoNS via AMPs | S8 | [‒4, ‒3] | [1, 2] | ‒3.44 | 1.88 |
| d8 | Elimination rate of CoNS through turnover | S8 | [‒2, ‒1] | [0, 1] | ‒1.73 | 0.40 |
| d9 | Elimination rate of IL-4/IL-13 | S9 | [‒9, ‒8] | [1, 2] | ‒8.62 | 1.19 |
| dA9a_s | Killing rate of S. aureus through ShA9 in bacteriocin‒sensitive S. aureus | S13 | [1, 2] | [0, 1] | 1.09 | 0.90 |
| dA9a_r | Killing rate of S. aureus through ShA9 in bacteriocin‒resistant S. aureus | S13 | [‒1, 0] | [0, 1] | ‒0.83 | 0.85 |
| dA9h | Killing rate of CoNS by ShA9 | S11 | [0, 1] | [0, 1] | 0.55 | 0.90 |
| bA9s | Inhibitory strength for agr expression through ShA9 | S12 | [‒2, ‒1] | [0, 1] | ‒1.11 | 0.27 |
| dfs | Killing rate of S. aureus by flucloxacillin | S14 | [0, 1] | [0, 1] | 0.13 | 0.27 |
| dfh | Killing rate of CoNS by flucloxacillin | S15 | [0, 1] | [0, 1] | 0.35 | 0.12 |
Abbreviations: agr, accessory gene regulatory; AMP, antimicrobial peptide; CoNS, coagulase-negative Staphylococcus; ShA9, Staphyloccocus hominis A9.